Article
Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 10 Apr 2015
Yang Jun J, Landier Wendy, Yang Wenjian, Liu Chengcheng, Hageman Lindsey, Cheng Cheng, Pei Deqing, Chen Yanjun, Crews Kristine R, Kornegay Nancy, Wong F Lennie, Evans William E, Pui Ching-Hon, Bhatia Smita, Relling Mary V
Abstract excerpt
PURPOSE: Mercaptopurine (MP) is the mainstay of curative therapy for acute lymphoblastic leukemia (ALL). We performed a genome-wide association study (GWAS) to identify comprehensively the genetic basis of MP intolerance in children with ALL. PATIENTS AND METHODS: The discovery GWAS and replication cohorts included 657 and 371 children from two prospective clinical trials. MP dose intensity was a marker for drug...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
